Wednesday, November 21st, 2018 - Paris
Official language: French
The world of clinical research is in a phase of profound transformation.
The acceleration of scientific knowledge in recent years is leading to a significant increase in the number of clinical trials with new drugs. This increase in study number is associated with methodological transformations.
To expedite market access to new drugs and to contain development costs, regulatory authorities, FDA and EMA, show readiness to accept new approaches including alternative experimental designs, early access models, risk based management of a numerous aspects of drug development pathway, use of Real Word Evidence data.
In this context, the operators involved in management of clinical research are facing a number of new challenges such as:
We are sure you will be as passionate as we are on these novel topics, the future is here, we need to shape it for providing enhanced solutions for a better health and quality of life for patients. This meeting will be a key opportunity to network and learn from knowledgeable speakers and experts of the area.
Anna Cali - Head of DCV Medical Affair at Sanofi Japan
Erick Gaussens - Executive Advisor and Chief Scientific Officer at ProductLife Group
Bertrand Sohier - Global Head, Respiratory, Critical Care, Cardiovascular and endocrinology Therapeutic Areas at PAREXEL
They will lead a panel of experts to share best practices, knowledge and experience in this field.
Representatives of Pharmaceutical and Biotechnology companies, Clinical Research Organizations, Academic centers, Hospital Centers, and Clinical Technology companies. Especially Clinical Research Professionals, belonging to the following departments:
• Clinical Research and Development
• Quality Assurance
• Clinical Operations
• Statistics and Data Management
• Information Technology
• Market Access
Taking part in our events, you support “The Vase of Flowers” project